FORM 4
OMB Approval
OMB Number 3235-0287
Expires: February 1, 1994
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
STATEMENT OF CHANGES IN BENEFICAL OWNERSHIP
Filed pursuant to Section 16(a) of the securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940
___ Check if no longer subject to Section 16, Form 4 or Form 5, Obligation may
continue. See Instructions
_X_ Form 3 Holdings Reported
___ Form 4 Transaction
<TABLE>
<S> <C>
1. Name and Address of Reporting Person: Volpe, Raymond
43 Taunton Green, 3rd Floor
Taunton, MA 02780
2. Issuer Name and Tickler or Trading Symbol: Surgical Safety Products,
Inc. NBMX
3. IRS or SSN of Reporting Person (Voluntary):
4. Statement for Month/Year September 1999
5. If Amendment, Date of Original:
6. Relation of Reporting Person to Issuer: _ Director
_ 10% owner
X Officer (Title): Division Manager MPD
_ Other (Specify):
X Filed by One Reporting
Person.
_ Filed by more than One
Reporting Person.
</TABLE>
<TABLE>
<CAPTION>
TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY
OWNED
<S> <C> <C> <C>
1. Title of Security: Common Stock C.S. Warrants
2. Transaction Date (M/D/Y): 09/17/99
3. Transaction Code (Instr 8): P V
4. Securities Acquired (A)
or Disposed (D) Amount: 32,060
(A) or (D): A
Price: 4,809
5. Amount of Securities
Beneficially Owned at
End of Month: 367,060
6. Ownership Form;
Direct (D) or Indirect (I): D
7. Nature of Indirect
Beneficial Ownership: N/A
</TABLE>
*If the form is filed by more than one Reporting Person, see instruction 5(b)(v)
Reminder: Report on a separate Line for each class of securities beneficially
owned directly or indirectly.
<PAGE>
<TABLE>
FORM 5 (continued)
TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED
<S> <C>
1. Title of Derivative Security: N/A
2. Conversion or Exercise Price of Derivative Security:
3. Transaction Date (M/D/Y):
4. Transaction Code:
V:
5. Number of Derivative Securities Aquired (A) or
Disposed of (D):
6. Date Exercisable:
Expiration Date:
7. Title of Underlying Securities:
Amount or number of Shares:
8. Price of Derivative Security:
9. Number of Derivative Securities Beneficially Owned
at end of Month:
10. Ownership of Derivative Securities;
(D) Direct or (I) Indirect:
11. Nature of Indirect Benefical Ownership:
</TABLE>
EXPLANATION OF RESPONSES: Consultant Fees
/s/ Raymond Volpe Date: 09/17/99
- --------------------------------
**Signature of Reporting Person
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See Sections 18 U.S.C. 1001, 15 U.S.C. 78ff(a).